001540 — Ahn-Gook Pharmaceutical Co Share Price
Last Trade - 00:00- KR₩138bn
- KR₩111bn
- KR₩141bn
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 174,002.38 | 183,599.89 | 185,745.62 | 155,851.76 | 143,364.22 | n/a | n/a | -6.23% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -69.43 | +166.5 | +61.92 | -69.72 | -98.81 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.
Directors
- Jun Seon Uh CHM (76)
- Jin Uh CCE (49)
- Se Yeong Cheon (49)
- Ha Taek Jung OTH (77)
- Cheol Min Kim (48)
- Jeong Hun Kim (50)
- Jae Jun Jung (54)
- Chun Sang Park (47)
- Heung Jun Yang (67)
- Last Annual
- December 31st, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- February 12th, 1959
- Public Since
- June 15th, 2000
- No. of Shareholders
- 8,972
- No. of Employees
- 606
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 11,459,146
- Address
- 613, Siheung-daero, Yeongdeungpo-gu, SEOUL, 07445
- Web
- http://ahn-gook.com
- Phone
- +82 232894200
- Auditors
- Ihnduck Accounting Corp.
Upcoming events for 001540
Similar to 001540
ARLICO PHARM ORD
Korea Exchange - KOSDAQ
BCWORLD PHARM ORD
Korea Exchange - KOSDAQ
BINEX ORD
Korea Exchange - KOSDAQ
CAREGEN ORD
Korea Exchange - KOSDAQ
CELLTRION PHARM ORD
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:57 UTC, shares in Ahn-Gook Pharmaceutical Co are trading at KR₩12,050. This share price information is delayed by 15 minutes.
Shares in Ahn-Gook Pharmaceutical Co last closed at KR₩12,050 and the price had moved by -24.14% over the past 365 days. In terms of relative price strength the Ahn-Gook Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -40.22% over the past year.
There is no consensus recommendation for this security.
The Ahn-Gook Pharmaceutical Co dividend yield is 1.83% based on the trailing twelve month period.
Last year, Ahn-Gook Pharmaceutical Co paid a total dividend of KR₩220, and it currently has a trailing dividend yield of 1.83%. We do not have any data on when Ahn-Gook Pharmaceutical Co is to next pay dividends.
We do not have data on when Ahn-Gook Pharmaceutical Co is to next pay dividends. The historic dividend yield on Ahn-Gook Pharmaceutical Co shares is currently 1.83%.
To buy shares in Ahn-Gook Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩12,050, shares in Ahn-Gook Pharmaceutical Co had a market capitalisation of KR₩138bn.
Here are the trading details for Ahn-Gook Pharmaceutical Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 001540
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Ahn-Gook Pharmaceutical Co does not currently have a style classification.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ahn-Gook Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -15.44%.
As of the last closing price of KR₩12,050, shares in Ahn-Gook Pharmaceutical Co were trading -10.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Ahn-Gook Pharmaceutical Co.
Ahn-Gook Pharmaceutical Co's management team is headed by:
- Jun Seon Uh - CHM
- Jin Uh - CCE
- Se Yeong Cheon -
- Ha Taek Jung - OTH
- Cheol Min Kim -
- Jeong Hun Kim -
- Jae Jun Jung -
- Chun Sang Park -
- Heung Jun Yang -
We do not have data on Ahn-Gook Pharmaceutical Co's shareholders